This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37262033
rdf:type
wikibase:Item
schema:description
article científic bilimsel makale مقالة علمية نشرت في 06 سبتمبر 2008 научни чланак wetenschappelijk artikel vetenskaplig artikel vedecký článok scientific article published on 06 September 2008 articolo scientifico videnskabelig artikel artículu científicu espublizáu en 2008 vědecký článek wissenschaftlicher Artikel article scientifique наукова стаття, опублікована у вересні 2008 artigo científico
p:P577
wds:Q37262033-C2754CF1-2ACE-4A02-92F6-A90B729E8842
wdt:P577
2008-09-06T00:00:00Z
p:P407
wds:Q37262033-F969D7A6-5356-4AF5-858A-3EEE4DFF1BE3
wdt:P407
wd:Q1860
p:P2093
wds:Q37262033-6A097FA6-E146-418A-B6EE-6F4857E9AFEF wds:Q37262033-D5692F68-C89C-4D20-B32E-5A1A49935992
wdt:P2093
Marie von Lilienfeld-Toal Mohamad Hussein
rdfs:label
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
skos:prefLabel
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
schema:name
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
p:P50
wds:Q37262033-E5C021A0-66C1-4E72-8329-882705F30CBA wds:Q37262033-C824999E-D9DC-47F3-B08E-6137A2D0FB95 wds:Q37262033-684DEC9D-6A88-4753-B04E-4306C40725ED wds:Q37262033-6E461213-1C6E-4E42-BDF8-19DDCA4A146A wds:Q37262033-24A56A24-3636-4863-A018-CC5D37C9050F wds:Q37262033-384331CC-7341-4B70-B48C-33BCE943A4ED wds:Q37262033-625F39E4-DB0D-4C84-AB19-C3ED72CB4794 wds:Q37262033-1F62CA56-E60C-4977-8237-D79C3FCF90F8
wdt:P50
wd:Q73546936 wd:Q26338766 wd:Q57306384 wd:Q5930658 wd:Q97590668 wd:Q87013105 wd:Q3167165 wd:Q89444139
p:P1476
wds:Q37262033-756DA9E7-4212-42D0-9F4C-6C41F4517D48
wdt:P1476
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
p:P304
wds:Q37262033-D8652295-1D94-4A68-BE1D-AAFC4DAA592C
wdt:P304
87-93
p:P31
wds:Q37262033-8F1DEB9B-5B7B-416C-810C-6EA1AE1FDF0D wds:Q37262033-823aec55-ab7b-4062-beb3-8433c3c9e3fb
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q37262033-67A4122B-FB01-4685-93C4-80B7E01AEA23
wdt:P921
wd:Q422252
p:P698
wds:Q37262033-2542AE52-AA9B-4BD5-A1B5-0F81D0331B8C
wdtn:P698
n6:18774632
wdt:P698
18774632
p:P1433
wds:Q37262033-DBCB8196-5A74-45B4-A9EA-C06A51233EFC
wdt:P1433
wd:Q15724415
p:P433
wds:Q37262033-A2818052-3D5D-4421-AE8B-71B636AB77BA
p:P478
wds:Q37262033-DD77B254-2C3A-49BB-967D-34F1423892F6
wdt:P433
2
wdt:P478
23
p:P356
wds:Q37262033-833A83C3-CCCA-4C3C-A9E5-8BFC69904A12
wdtn:P356
n12:J.BLRE.2008.07.003
wdt:P356
10.1016/J.BLRE.2008.07.003